Search

everythinglearnresearchcommunity

for

Search:↓

Men with depression and marijuana usage are more likely to be treated for lower urinary tract symptoms/benign prostatic hyperplasia.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Obesity is linked to more severe lower urinary tract symptoms.

Saw palmetto is not proven to improve urinary flow, prostate size, or hair loss.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Finasteride is a cost-effective option for treating BPH, reducing risk of urinary issues and surgery.

Chewing betel nut may increase the risk of type 2 diabetes, and saw palmetto can improve urinary symptoms in BPH with fewer side effects but may cause bleeding and allergic reactions.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

The document highlights recent findings and treatments in urology, including prostate cancer diagnostics, urinary incontinence, and new therapies.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

Children with partial biotinidase deficiency are healthy at birth but may develop symptoms that improve with biotin therapy.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Biotin deficiency in patients on total parenteral nutrition can cause serious symptoms but can be treated with biotin supplements.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Most patients with Porphyria Cutanea Tarda had skin blisters and were often affected by hepatitis C and alcohol abuse, with differences between familial and sporadic cases.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Higher fluoride levels may delay puberty in boys.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.